Coverage
-
September 06, 2016
A Florida federal judge on Tuesday cleared Canadian generics maker Apotex Inc. of patent infringement claims brought by pharmaceutical firm Amgen Inc. related to its blockbuster biologic Neulasta, saying that Amgen didn't prove how Apotex's biosimilars infringed but stopping short of awarding attorneys' fees.
5 other articles on this case.
View all »